Connecting you to content on EBSCOhost

Works matching IS 03407004 AND DT 2002 AND VI 51 AND IP 5

Results: 7

1

Is the presence of interleukin-2 receptor alpha in the serum of colorectal liver metastases patients derived from hepatic natural killer cells?

Published in:: Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 291, doi. 10.1007/s00262-002-0289-z
Publication type:: Article

2

Prediction of an HLA-DR-binding peptide derived from Wilms' tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124–138)-pulsed dendritic cells generated according to an optimised protocol.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 271, doi. 10.1007/s00262-002-0278-2

By:

Knights, Ashley;
Zaniou, Angeliki;
Rees, Robert C.;
Pawelec, Graham;
Müller, Ludmila

Publication type:

Article

3

The role of CD8<sup>+</sup> T cells in immune responses to colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 235, doi. 10.1007/s00262-002-0276-4

By:

Titu, Liviu V.;
Monson, John R.;
Greenman, John

Publication type:

Article

4

Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 263, doi. 10.1007/s00262-002-0281-7

By:

Perambakam, Supriya;
Bao-Hua Xue;
Sosman, Jeffrey A.;
Peace, David J.

Publication type:

Article

5

Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-A24-recoverin tetramer.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 282, doi. 10.1007/s00262-002-0282-6

By:

Rong, Shunshui;
Ikeda, Hideyuki;
Sato, Yuriko;
Hirohashi, Yoshihiko;
Takamura, Yukio;
Sahara, Hiroeki;
Sato, Takashi;
Maeda, Akiko;
Ohguro, Hiroshi;
Sato, Noriyuki

Publication type:

Article

6

Treatment with GM-CSF and IL-2 in patients with metastatic colorectal carcinoma induced high serum levels of neopterin and sIL-2R, an indicator of immune suppression.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 255, doi. 10.1007/s00262-002-0279-1

By:

Skog, Hjelm A.-L.;
Wersäll, P.;
Ragnhammar, P.;
Frödin, J.-E.;
Mellstedt, Håkan

Publication type:

Article

7

Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 248, doi. 10.1007/s00262-002-0275-5

By:

Wu, Shanshan;
Murrell, George A.;
Yao Wang

Publication type:

Article